<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="097819-2018"
            EDITION="2018045">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-100422-001</RECEPTION_ID>
      <DELETION_DATE>20180405</DELETION_DATE>
      <FORM_LG_LIST>ET </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>45</NO_OJ>
         <DATE_PUB>20180306</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 045-097819</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="ET">http://ted.europa.eu/udl?uri=TED:NOTICE:097819-2018:TEXT:ET:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>ET</LG_ORIG>
         <ISO_COUNTRY VALUE="EE"/>
         <IA_URL_GENERAL>http://www.kliinikum.ee</IA_URL_GENERAL>
         <IA_URL_ETENDERING>https://riigihanked.riik.ee/register/hange/195482</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33652300">Immunosuppressive agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="EE">EESTI</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="EE">EESTI</n2016:CA_CE_NUTS>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180302</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180405 10:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B02</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Ecтoния</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Имуноподтискащи средства</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Estonsko</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imunosupresiva</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Estland</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunsuppressive midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Estland</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunsuppressiva</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Εσθονία</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Ανοσοκατασταλτικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Estonia</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunosuppressive agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Estonia</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Inmunosupresores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Eesti</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immuunsupressiivsed ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Viro</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunosupressiiviset lääkeaineet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Estonie</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunosuppresseurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Eastóin, an</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunosuppressive agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Estonija</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imunosupresivi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Észtország</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunszuppresszív szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Estonia</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Agenti immunosoppressivi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Estija</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imunosupresantai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Igaunija</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imūnsupresīvie līdzekļi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>l-Estonja</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Aġenti immunosupressivi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Estland</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunosuppresiemiddelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Estonia</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Środki immunosupresyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Estónia</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imunossupressores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Estonia</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imunosupresoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Estónsko</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Imunosupresívne činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Estonija</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Zdravila za zaviranje imunske odzivnosti</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Estland</TI_CY>
            <TI_TOWN>Tartu</TI_TOWN>
            <TI_TEXT>
               <P>Immunsuppressiva medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="ET">Sihtasutus Tartu Ülikooli Kliinikum</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>0df6eb9e-287c-4aab-b1ee-3094077d637e</NOTICE_UUID>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="ET">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Sihtasutus Tartu Ülikooli Kliinikum</OFFICIALNAME>
               <NATIONALID>90001478</NATIONALID>
               <ADDRESS>Puusepa 1a</ADDRESS>
               <TOWN>Tartu</TOWN>
               <POSTAL_CODE>50406</POSTAL_CODE>
               <COUNTRY VALUE="EE"/>
               <CONTACT_POINT>Heli Vatman</CONTACT_POINT>
               <PHONE>+372 7319425</PHONE>
               <E_MAIL>heli.vatman@kliinikum.ee</E_MAIL>
               <FAX>+372 7319402</FAX>
               <n2016:NUTS CODE="EE"/>
               <URL_GENERAL>http://www.kliinikum.ee</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>https://riigihanked.riik.ee/register/hange/195482</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>https://riigihanked.riik.ee/register/hange/195482</URL_PARTICIPATION>
            <ADDRESS_PARTICIPATION_IDEM/>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Bioloogiliste ravimite ostmine vastavalt nimekirjale</P>
            </TITLE>
            <REFERENCE_NUMBER>195482</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33652300"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi Lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
            </SHORT_DESCR>
            <LOT_DIVISION>
               <LOT_MAX_NUMBER>15</LOT_MAX_NUMBER>
            </LOT_DIVISION>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>L04AA11 Etanertsept bioriginaal</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>L04AA11 Etanertsept biosimilar</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>L04AB02 Infliksimab biooriginaal</P>
               </TITLE>
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>L04AB02 Infliksimab biosimilar</P>
               </TITLE>
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <TITLE>
                  <P>L04AB04 Adalimumab</P>
               </TITLE>
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <TITLE>
                  <P>L04AB06 Golimumab</P>
               </TITLE>
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <TITLE>
                  <P>L04AC05 Ustekinumab</P>
               </TITLE>
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <TITLE>
                  <P>L04AC07 Tocilizumab</P>
               </TITLE>
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <TITLE>
                  <P>L04AC07 Tocilizumab</P>
               </TITLE>
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <TITLE>
                  <P>L04AA23 Natalizumab</P>
               </TITLE>
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <TITLE>
                  <P>L04AA34 Alemtuzumab</P>
               </TITLE>
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <TITLE>
                  <P>L04AC10 Secukinumab</P>
               </TITLE>
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <TITLE>
                  <P>L04AC16 Guselkumab</P>
               </TITLE>
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <TITLE>
                  <P>R03DX05 Omalizumab</P>
               </TITLE>
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <TITLE>
                  <P>R03DX09 Mepolizumab</P>
               </TITLE>
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33652300"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="EE"/>
               <SHORT_DESCR>
                  <P>Käesoleva hanke objektiks on bioloogiliste ravimite ostmine vastavalt nimekirjale hankedokumendi lisas 1 toodud nimetuste ja kirjelduste alusel.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <DURATION TYPE="MONTH">24</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <LEFTI>
            <ECONOMIC_FINANCIAL_INFO>
               <P>1) 1.Pakkuja viimase (2016) majandusaasta netokäive kokku peab olema vähemalt 200 000 EUR.</P>
               <P>Pakkuja esitab kinnituse ja andmed enda majandusliku ja finantsseisundi hindamiseks hankepassis.</P>
            </ECONOMIC_FINANCIAL_INFO>
            <TECHNICAL_PROFESSIONAL_INFO>
               <P>1) Pakkuja peab omama tegevusluba ravimite hulgimüügiks Eesti Vabariigis.</P>
               <P>Pakkuja kinnitab enda tegevusloa olemasolu hankepassis. Hankija kontrollib iseseisvalt pakkuja tegevusloa olemasolu Ravimiameti poolt hallatava tegevuslubade registri vahendusel.</P>
            </TECHNICAL_PROFESSIONAL_INFO>
         </LEFTI>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK>
               <SINGLE_OPERATOR/>
            </FRAMEWORK>
            <NO_CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-04-05</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>10:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="ET"/>
            </LANGUAGES>
            <DURATION_TENDER_VALID TYPE="MONTH">2</DURATION_TENDER_VALID>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-04-05</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>10:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Riigihangete vaidlustuskomisjon</OFFICIALNAME>
               <ADDRESS>Endla 13/Lõkke 5</ADDRESS>
               <TOWN>Tallinn</TOWN>
               <POSTAL_CODE>10122</POSTAL_CODE>
               <COUNTRY VALUE="EE"/>
               <PHONE>+372 6113713</PHONE>
               <E_MAIL>vako@fin.ee</E_MAIL>
               <FAX>+372 6113760</FAX>
               <URL>http://www.fin.ee/riigihangete-poliitika</URL>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Riigihangete vaidlustuskomisjon</OFFICIALNAME>
               <ADDRESS>Endla 13/Lõkke 5</ADDRESS>
               <TOWN>Tallinn</TOWN>
               <POSTAL_CODE>10122</POSTAL_CODE>
               <COUNTRY VALUE="EE"/>
               <PHONE>+372 6113713</PHONE>
               <E_MAIL>vako@fin.ee</E_MAIL>
               <FAX>+372 6113760</FAX>
               <URL>http://www.fin.ee/riigihangete-poliitika</URL>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-03-02</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
